Thank you I agree. As a spec stock it appears strong based on what seems to be medical research with integrity and registered technology patents etc. Perhaps the best endorsement is from AGC. I cant imagine AGC would be investing millions without a positive, substantiated view.
I note with the Edison's latest research, valuation excludes these derived from some current technologies. This could be a good long term story.
Re-rate, page-14
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
